Assessment of pregnancy outcomes in patients treated with Ajovy (fremanezumab): pregnancy database study

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/40050
• EU PAS number:
  EUPAS38434
• Study ID:
  40050
• Official title and acronym:
  Assessment of pregnancy outcomes in patients treated with Ajovy (fremanezumab): pregnancy database study
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study status:
  Ongoing

Research institutions and networks

Institutions

HealthCore

Study timelines

Date when funding contract was signed

Planned: 18/02/2020

Study start date

Planned: 31/12/2020

Actual: 09/12/2020

Date of final study report

Planned: 31/12/2028

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Teva Branded Pharmaceutical Products R&D, Inc.

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable